D
Exact Sciences Corporation EXAS
$102.26 -$0.11-0.11% NASDAQ
Recommendation
Prev Close
$102.26
Volume
1,858,018
Avg Vol (90D)
4,412,878
Market Cap
$19.41B
Dividend & Yield
--
52-Week Range
$38.81 - $102.66
P/E (TTM)
--
EPS (TTM)
-$5.33
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Baillie Gifford & Co. Lowers Holdings in Exact Sciences Corporation $EXAS
1/25/2026 - MarketBeat
A Look At Exact Sciences (EXAS) Valuation After Its Recent 90 Day Share Price Surge
1/25/2026 - Simply Wall St
Is It Time To Reassess Exact Sciences (EXAS) After Its Strong One Year Share Price Run?
1/23/2026 - Simply Wall St
ABT Q4 Deep Dive: Nutrition Weakness and Innovation Shape 2026 Outlook
1/23/2026 - StockStory Articles
Abbott Broadens Cardiology And Oncology Reach As Valuation Questions Persist
1/22/2026 - Simply Wall St
Exact Sciences (NASDAQ:EXAS) Sets New 1-Year High - What's Next?
1/22/2026 - MarketBeat
Abbott says 'making great progress' towards closing Exact Sciences deal
1/22/2026 - The Fly
Abbott says 'making great progress' towards closing Exact Sciences deal
1/22/2026 - The Fly
Abbott still sees Exact Sciences acquisition closing in Q2
1/22/2026 - The Fly
QRG Capital Management Inc. Has $641,000 Holdings in Exact Sciences Corporation $EXAS
1/22/2026 - MarketBeat
Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights
1/21/2026 - Globe Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS
1/21/2026 - PR Newswire
Video: Wednesday's ETF with Unusual Volume: FBT
1/21/2026 - Market News Video
Park Capital Management, LLC / WI Buys 2,305 Shares of Exact Sciences Corp (EXAS)
1/21/2026 - GuruFocus
Exact Sciences (NASDAQ:EXAS) Lowered to Hold Rating by Mizuho
1/21/2026 - Ticker Report
Exact Sciences (NASDAQ:EXAS) Lowered to Hold Rating by Mizuho
1/21/2026 - MarketBeat
HARBOR CAPITAL ADVISORS, INC. Sells 18,705 Shares of Exact Sciences Corp (EXAS)
1/20/2026 - GuruFocus
Assessing Exact Sciences: Insights From 16 Financial Analysts
1/20/2026 - Benzinga
Exact Sciences (EXAS) Downgraded by Mizuho, Price Target Raised to $105 EXAS Stock News
1/20/2026 - GuruFocus
Essex LLC Buys 2,900 Shares of Exact Sciences Corp (EXAS)
1/20/2026 - GuruFocus
Exact Sciences (EXAS) Rose Following the Acquisition Announcement by Abbott
1/20/2026 - Yahoo! Finance: News
Exact Sciences (EXAS) Rose Following the Acquisition Announcement by Abbott
1/20/2026 - Insider Monkey
Exact Sciences Corporation $EXAS Stock Position Boosted by Massachusetts Financial Services Co. MA
1/20/2026 - MarketBeat
Exact Sciences just downgraded at Mizuho, here's why
1/20/2026 - The Fly
Exact Sciences just downgraded at Mizuho, here's why
1/20/2026 - The Fly
Income Statement
Total Revenue (TTM)
$3.08B
EBITDA (TTM)
$96.88M
EBIT (TTM)
-$121.49M
Net Income (TTM)
-$986.58M
Balance Sheet
Total Assets (Q)
$5.90B
Total Debt (Q)
$2.54B
Total Liabilities (Q)
$3.40B
Book Value Per Share (Q)
$13.20
Cash Flow
Cash from Operations (TTM)
$386.81M
Cash from Investing (TTM)
$62.13M
Cash from Financing (TTM)
-$251.72M
Net Change in Cash (TTM)
$194.37M
Filings
Filing Date
Monday, November 3, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
0.25
7-Day Total Return
0.00%
30-Day Total Return
1.00%
60-Day Total Return
61.55%
90-Day Total Return
93.16%
Year to Date Total Return
0.51%
1-Year Total Return
82.67%
2-Year Total Return
59.23%
3-Year Total Return
56.60%
5-Year Total Return
-33.57%
52-week Low
Aug 07, 2025 - $38.81
52-week High
Dec 19, 2025 - $102.66
Valuation
Market Cap
$19.41B - Large Cap
Enterprise Value
$20.94B
Price/Sales (TTM)
6.28
Price/Book (Q)
7.74
Dividends and Shares
Shares Outstanding
189.26M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.exactsciences.com
Phone Number
608 284 5700
Address
5505 Endeavor Lane
Madison, WI 53719
Country
United States
Year Founded
1995
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to... more
NASDAQ 01/23/2026 4:00PM Eastern Quotes delayed